Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-24 @ 11:02 PM
Study NCT ID:
NCT04414969
Status:
UNKNOWN
Last Update Posted:
2020-07-07
First Post:
2020-05-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma
Sponsor:
Hunan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-31
First Submit QC Date:
None
Study First Post Date:
2020-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-02
Last Update Post Date:
2020-07-07
Last Update Post Date Type:
ACTUAL